GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $206,000 | -22.6% | 4,735 | -22.4% | 0.03% | -12.1% |
Q1 2022 | $266,000 | +1.9% | 6,103 | +3.2% | 0.03% | +3.1% |
Q4 2021 | $261,000 | +13.0% | 5,913 | -2.2% | 0.03% | +3.2% |
Q3 2021 | $231,000 | +14.4% | 6,045 | +6.7% | 0.03% | -24.4% |
Q1 2021 | $202,000 | -1.5% | 5,664 | +0.4% | 0.04% | -14.6% |
Q4 2020 | $205,000 | -8.1% | 5,640 | -4.7% | 0.05% | -21.3% |
Q3 2020 | $223,000 | -19.5% | 5,921 | -13.3% | 0.06% | -26.5% |
Q2 2020 | $277,000 | +8.6% | 6,829 | +1.5% | 0.08% | -9.8% |
Q1 2020 | $255,000 | -21.1% | 6,725 | -2.0% | 0.09% | 0.0% |
Q4 2019 | $323,000 | +6.6% | 6,861 | -2.9% | 0.09% | -2.1% |
Q3 2019 | $303,000 | +7.1% | 7,068 | -0.5% | 0.09% | +16.0% |
Q2 2019 | $283,000 | +26.9% | 7,104 | +34.0% | 0.08% | +22.7% |
Q1 2019 | $223,000 | +11.5% | 5,300 | +10.9% | 0.07% | -31.2% |
Q1 2017 | $200,000 | – | 4,779 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |